Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/8724530

Download in:

View as

General Info

PMID
8724530